Associated Papers
Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis.
Park JE et al.
Cancers, 2024
39409938 (PubMed )
Supplement: cancers-16-03318-s001.zip › cancers-3195289-supplementary.pdf
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
Fasching PA et al.
Npj Breast Cancer, 2024
39003306 (PubMed )
Supplement: 41523_2024_667_MOESM1_ESM.pdf
Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape.
Abu-Hijlih R et al.
Cancers, 2024
38730621 (PubMed )
Supplement: cancers-16-01668-s001.zip › Table_Suppl_2.pdf
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls.
Zanti M et al.
Frontiers in Genetics, 2023
37790698 (PubMed )
Supplement: DataSheet1.xlsx › Table_S2
Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
Murali K et al.
Hereditary Cancer in Clinical Practice, 2021
Performance evaluation of pipelines for mapping, variant calling and interval padding, for the analysis of NGS germline panels.
Zanti M et al.
Bmc Bioinformatics, 2021
NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases.
Zanti M et al.
Cancers, 2020
Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer.
Macklin-Mantia SK et al.
Hereditary Cancer in Clinical Practice, 2020
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Girard E et al.
International Journal of Cancer, 2019
30303537 (PubMed )
Supplement: IJC-144-1962-s006.pdf
Select a paper to view details